Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 3/20 | 0.81 |
| ▸ | NT5E | P21589 | 2/20 | 0.79 |
| ▸ | CASP6 | P55212 | 4/20 | 0.66 |
| ▸ | NSD2 | O96028 | 3/20 | 0.66 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.66 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.66 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.66 |
| ▸ | CASP7 | P55210 | 1/20 | 0.66 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.59 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.55 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10900036 | 1.00 | PRMT1 (0.81) | PRMT1NT5ECASP6NSD2DUSP3 | |
| SCHEMBL16255037 | 0.92 | PRMT1 (0.69) | PRMT1NT5ECASP6NSD2DUSP3 | |
| SCHEMBL11211030 | 0.91 | PRMT1 (0.67) | PRMT1NT5ECASP6NSD2DUSP3 | |
| SCHEMBL11489790 | 0.90 | PRMT1 (0.66) | PRMT1NT5ECASP6NSD2DUSP3 | |
| SCHEMBL29349608 | 0.89 | PRMT1 (1.00) | PRMT1NT5ECASP6NSD2DUSP3 | |
| SCHEMBL2679101 | 0.89 | PRMT1 (1.00) | PRMT1NT5ECASP6NSD2DUSP3 | |
| SCHEMBL6079067 | 0.89 | PRMT1 (1.00) | PRMT1NT5ECASP6NSD2DUSP3 | |
| SCHEMBL8439783 | 0.88 | NT5E (1.00) | PRMT1NT5ECASP6NSD2DUSP3 | |
| SCHEMBL1803097 | 0.88 | NT5E (0.75) | PRMT1NT5ECASP6NSD2DUSP3 | |
| SCHEMBL10823488 | 0.88 | PRMT1 (0.64) | PRMT1NT5ECASP6NSD2DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115280435-B | Anisotropic rare earth sintered magnet and method for producing same | 信越化学工业株式会社 | 2026-02-27 | — | — | CN | disclosed |
| US-12552882-B2 | Polymeric disinfectants and uses thereof | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2026-02-17 | — | — | US | disclosed |
| US-20250387582-A1 | PATIENT INTERFACE AND COMPONENT PARTS | FISHER & PAYKEL HEALTHCARE LTD (NZ) | 2025-12-25 | — | — | US | disclosed |
| US-12499971-B2 | Systematic screening and mapping of regulatory elements in non-coding genomic regions, methods, compositions, and applications thereof | THE BROAD INSTITUTE, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| EP-4237493-B1 | POLYMERIC DISINFECTANTS AND USES THEREOF | TECHNION RES & DEV FOUNDATION (IL) | 2025-12-10 | — | — | EP | disclosed |
| US-20250346862-A1 | METHODS FOR THE RE-DERIVATION OF DIVERSE PLURIPOTENT STEM CELL-DERIVED BROWN FAT CELLS | AgeX Therapeutics,Inc. (US) | 2025-11-13 | — | — | US | disclosed |
| US-12410116-B2 | Compounds and use thereof in methods of treatment | THE UNIVERSITY OF QUEENSLAND (AU) | 2025-09-09 | — | — | US | disclosed |
| US-12404493-B2 | Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells | AGEX THERAPEUTICS, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| US-20250223579-A1 | NOVEL CRISPR ENZYMES AND SYSTEMS | BROAD INST INC (US) | 2025-07-10 | — | — | US | disclosed |
| US-20250179453-A1 | CRISPR ENZYME MUTATIONS REDUCING OFF-TARGET EFFECTS | THE BROAD INSTITUTE, INC. (US) | 2025-06-05 | — | — | US | disclosed |
| US-11591601-B2 | Methods for identification and modification of lncRNA associated with target genotypes and phenotypes | THE BROAD INSTITUTE, INC. (US) | 2023-02-28 | — | — | US | disclosed |
| EP-4130301-A1 | ANISOTROPIC RARE-EARTH SINTERED MAGNET AND METHOD FOR PRODUCING SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2023-02-08 | — | — | EP | disclosed |
| CN-115433707-A | Method for the re-derivation of brown adipocytes derived from different pluripotent stem cells | 再生疗法有限公司 | 2022-12-06 | — | — | CN | disclosed |
| EP-2838721-B9 | METHOD FOR MANUFACTURING A SET OF EMBOSSING ROLLERS | BOEGLI GRAVURES SA (CH) | 2022-09-21 | — | — | EP | disclosed |
| US-11434190-B2 | Inhibitors of SOX18 protein activity for treating angiogenesis-and/or lymphangiogenesis-related diseases | THE UNIVERSITY OF QUEENSLAND (AU) | 2022-09-06 | — | — | US | disclosed |
| CN-114930257-A | Control device and method for controlling variable physical parameters | 钟国诚 | 2022-08-19 | — | — | CN | disclosed |
| CN-110721383-B | Patient interface and component | 费雪派克医疗保健有限公司 | 2022-07-26 | — | — | CN | disclosed |
| WO-2022091091-A1 | POLYMERIC DISINFECTANTS AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2022-05-05 | — | — | WO | disclosed |
| CN-108779435-B | Method for the re-derivation of different pluripotent stem cell-derived brown adipocytes | 再生疗法有限公司 | 2022-05-03 | — | — | CN | disclosed |
| EP-3950673-A1 | INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF | Inspirna, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11434190-B2 | Inhibitors of SOX18 protein activity for treating angiogenesis-and/or lymphangiogenesis-related diseases | SOX18, PROX1, RUNX1 | PRMT1 2082/4885NT5E 3282/4885CASP6 3482/4885 |
| US-20250387582-A1 | PATIENT INTERFACE AND COMPONENT PARTS | RAE1, EXOSC9, SET | PRMT1 1408/4885NT5E 303/4885CASP6 3271/4885 |
| US-12552882-B2 | Polymeric disinfectants and uses thereof | PIK3C3, POLR1C, CUTA | PRMT1 1828/4885NT5E 2774/4885CASP6 1026/4885 |
| US-12410116-B2 | Compounds and use thereof in methods of treatment | SOX18, PROX1, RUNX1 | PRMT1 2285/4885NT5E 3125/4885CASP6 2999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.